[go: up one dir, main page]

AU2001269799A1 - Methods for treating various eye disorders - Google Patents

Methods for treating various eye disorders

Info

Publication number
AU2001269799A1
AU2001269799A1 AU2001269799A AU6979901A AU2001269799A1 AU 2001269799 A1 AU2001269799 A1 AU 2001269799A1 AU 2001269799 A AU2001269799 A AU 2001269799A AU 6979901 A AU6979901 A AU 6979901A AU 2001269799 A1 AU2001269799 A1 AU 2001269799A1
Authority
AU
Australia
Prior art keywords
methods
treating various
eye disorders
various eye
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269799A
Inventor
Gerard M. Nolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOLAN EYE AND LASER CENTER
Original Assignee
NOLAN EYE AND LASER CT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOLAN EYE AND LASER CT filed Critical NOLAN EYE AND LASER CT
Publication of AU2001269799A1 publication Critical patent/AU2001269799A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001269799A 2000-09-22 2001-06-12 Methods for treating various eye disorders Abandoned AU2001269799A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09667270 2000-09-22
US09/667,270 US6273092B1 (en) 2000-09-22 2000-09-22 Methods for treating various eye disorders
PCT/US2001/018904 WO2002024059A1 (en) 2000-09-22 2001-06-12 Methods for treating various eye disorders

Publications (1)

Publication Number Publication Date
AU2001269799A1 true AU2001269799A1 (en) 2002-04-02

Family

ID=24677530

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269799A Abandoned AU2001269799A1 (en) 2000-09-22 2001-06-12 Methods for treating various eye disorders

Country Status (5)

Country Link
US (1) US6273092B1 (en)
EP (1) EP1328186A4 (en)
AU (1) AU2001269799A1 (en)
CA (1) CA2422983A1 (en)
WO (1) WO2002024059A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
US6605640B2 (en) 2001-01-31 2003-08-12 Gerard M. Nolan Method of treating certain eye diseases
US6540990B2 (en) * 2000-09-22 2003-04-01 Gerard M. Nolan Physiological method of improving vision
CA2522043A1 (en) * 2003-04-25 2004-11-11 Gerard M. Nolan Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
US7033026B2 (en) * 2003-07-04 2006-04-25 Spector Robert T Method of and apparatus for diagnosing and treating amblyopic conditions in the human visual system
RU2251997C2 (en) * 2003-07-08 2005-05-20 ООО "Медицинская научно-Производственная фирма "НОВЫЙ ВЗГЛЯД" Method for treating dry-eye syndrome
US7413566B2 (en) * 2005-05-19 2008-08-19 Amo Manufacturing Usa, Llc Training enhanced pseudo accommodation methods, systems and devices for mitigation of presbyopia
US8133216B2 (en) 2006-10-16 2012-03-13 Syneron Medical Ltd. Methods and devices for treating tissue
US8273080B2 (en) 2006-10-16 2012-09-25 Syneron Medical Ltd. Methods and devices for treating tissue
US8142426B2 (en) 2006-10-16 2012-03-27 Syneron Medical Ltd. Methods and devices for treating tissue
US8007493B2 (en) 2006-10-16 2011-08-30 Syneron Medical Ltd. Methods and devices for treating tissue
EP1938839B1 (en) * 2006-12-18 2009-08-19 Jorge Luis Benozzi Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia
US8845630B2 (en) 2007-06-15 2014-09-30 Syneron Medical Ltd Devices and methods for percutaneous energy delivery
US20090112205A1 (en) * 2007-10-31 2009-04-30 Primaeva Medical, Inc. Cartridge electrode device
US20090156958A1 (en) * 2007-12-12 2009-06-18 Mehta Bankim H Devices and methods for percutaneous energy delivery
RU2377965C1 (en) * 2008-04-18 2010-01-10 Государственное учреждение Научно-исследовательский институт глазных болезней Российской академии медицинских наук (ГУ НИИГБ РАМН) Method of treating deficiency in basal lachrymal secretion
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US9345696B2 (en) * 2010-11-12 2016-05-24 The Children's Medical Center Corporation Methods for treating nicotinic acetylcholine receptor associated diseases
AU2012311239B2 (en) 2011-09-20 2017-10-19 Allergan, Inc. Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
AU2015227307A1 (en) 2014-03-03 2016-10-13 Encore Vision, Inc. Lipoic acid choline ester compositions and methods of use
CN113230021A (en) 2015-01-12 2021-08-10 科达莱昂治疗公司 Droplet delivery apparatus and method
AU2016246060B2 (en) 2015-04-10 2020-10-22 Bausch + Lomb Ireland Limited Piezoelectric dispenser with replaceable ampoule
WO2017210158A1 (en) * 2016-06-01 2017-12-07 Hellstrom Harold R Treatment of dry eye disease with parasympathetic and anti-sympathetic agents
ES2934790T3 (en) 2016-08-19 2023-02-27 Orasis Pharmaceuticals Ltd Ophthalmic pharmaceutical compositions and uses related thereto
CN109906120A (en) 2017-01-20 2019-06-18 科达莱昂治疗公司 Piezoelectric fluid distributor
JP7274475B2 (en) 2017-07-20 2023-05-16 セインダ ファーマシューティカル グアンジョウ コーポレイション Compositions and methods for the treatment of myopia
JP7436363B2 (en) 2017-12-08 2024-02-21 ノバルティス アーゲー fluid delivery alignment system
US12350194B1 (en) 2018-04-12 2025-07-08 Bausch + Lomb Ireland Limited Topical ocular delivery of fluids with controlled mass dosing and wireless communication
US20190314197A1 (en) 2018-04-12 2019-10-17 Kedalion Therapeutics, Inc. Topical Ocular Delivery Methods and Devices for Use in the Same
EP3681500B2 (en) 2018-04-24 2025-07-30 Allergan, Inc. Use of pilocarpine hydrochloride for the treatment of presbyopia
KR102827233B1 (en) 2018-07-03 2025-06-30 보슈 롬 아일랜드 리미티드 Local ocular delivery devices and methods for using the same
EP3833340A4 (en) * 2018-08-08 2021-09-29 Seinda Pharmaceutical Guangzhou Corporation Compositions and methods for treatment of presbyopia
US12097145B2 (en) 2019-03-06 2024-09-24 Bausch + Lomb Ireland Limited Vented multi-dose ocular fluid delivery system
US11679028B2 (en) 2019-03-06 2023-06-20 Novartis Ag Multi-dose ocular fluid delivery system
WO2021026653A1 (en) * 2019-08-13 2021-02-18 The Royal Institution For The Advancement Of Learning / Mcgill University Cholinergic potentiation of binocular vision
US12496218B1 (en) 2019-11-12 2025-12-16 Bausch + Lomb Ireland Limited Fractionated topical ocular drug delivery methods and devices for use in the same
US11925577B2 (en) 2020-04-17 2024-03-12 Bausch + Lomb Ireland Limted Hydrodynamically actuated preservative free dispensing system
US11938057B2 (en) 2020-04-17 2024-03-26 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
US12290472B2 (en) 2020-04-17 2025-05-06 Bausch + Lomb Ireland Limited Hydrodynamically actuated preservative free dispensing system
EP4120973A4 (en) 2020-04-17 2024-04-17 Bausch + Lomb Ireland Limited HYDRODYNAMIC ACTUATED PRESERVATIVE-FREE DISPENSING SYSTEM WITH COLLAPSIBLE LIQUID CONTAINER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826258A (en) * 1972-02-07 1974-07-30 S Abraham Gradual release medicine carrier
US5778893A (en) * 1991-04-01 1998-07-14 President And Fellows Of Harvard College Method of diagnosing and monitoring a treatment for Alzheimer's disease

Also Published As

Publication number Publication date
US6273092B1 (en) 2001-08-14
EP1328186A1 (en) 2003-07-23
EP1328186A4 (en) 2006-03-22
CA2422983A1 (en) 2002-03-28
WO2002024059A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001269799A1 (en) Methods for treating various eye disorders
AU2001227837A1 (en) Novel treatment for eye disease
AU2001285159A1 (en) Methods for treating endocrine disorders
AU2001245283A1 (en) Methods for treating aneurysms
AU2001238369A1 (en) Method for treating thyroid disorders
AUPQ514600A0 (en) Brain injury treatment
AU2001238472A1 (en) Method for treating parathyroid disorders
AU2002224417A1 (en) Methods for treating il-18 mediated disorders
AU7085100A (en) Method for treating otic disorders
AU2002215125A1 (en) Well treatment method
EP1414464A4 (en) Method for treating glaucoma v
AU2001219185A1 (en) 2-acylaminobenzimidazole derivatives for treating glaucoma
AU2003210597A1 (en) Methods for treating eye disorders
EP1210915A3 (en) Laser treatment apparatus
AU2001252605A1 (en) Laser treatment apparatus
AU8298801A (en) Methods for treating atopic disorders
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU2001237939A1 (en) Methods for treating glaucoma
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU2002241670A1 (en) Method for treating glaucoma IB
AU2002245204A1 (en) Methods for treating blood coagulation disorders
AU2002320352A1 (en) Methods for treating or preventing sclerotic disorders using cd2-binding agents
AU4175099A (en) Medium for treating eye diseases
AU1603401A (en) Pyranoindoles for treating glaucoma
AU2002225327A1 (en) Apparatus for aesthetic treatment